Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global anesthesia drugs market is expected to register a CAGR of 3.5% during the forecast period (2018 - 2023). Anesthetic is a drug which causes anesthesia, it is a reversible loss of sensation. There are several types of anesthetic drugs available in the market, such as the general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia, etc.
Rise in the Number of Surgeries
According to the Center for Disease Control and Prevention (CDC), the total number of inpatient surgeries performed in the United States grew from 48 million in 2009 to 51.4 million in 2010, with cardiology, surgical, and obstetrical procedures being the most common ones. The number of surgeries being performed is rising every year. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as anesthetic drugs are used in surgical procedures to reduce the pain during surgery. Along with rising surgeries, other factors such as new anesthetic drugs and reduction in the cost of newly invented drugs are also driving the market.
Side Effects of General Anesthesia
General anesthetic drugs cause several side effects including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes, such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and to provide blood pressure medications if required. Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it, along with lack of skilled anesthetics and regulatory issues are restraining the market growth.
North America to dominate the Market
North America has the largest regional market share with revenue estimated to be over 32%. Some of the major driving forces that account for such growth in this region are the increase in a number of general and emergency surgeries, increase in cardiovascular and respiratory diseases, and rise in aging population. From the technology point of view, advancements in the development of new anesthesia drugs are a prime driving force of the market. Asia-Pacific was estimated to register the fastest CAGR through the forecast period (2018-2023).
Key Developments in the Market
• September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
• April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.
Major Players: BAXTER HEALTHCARE, HOSPIRA, ABBOTT LABORATORIES, ASTRA ZENECA, ROCHE HOLDING AG, B. BRAUN MELSUNGEN AG, ABBVIE, BOEHRINGER INGELHEIM, EISAI, FRESENIUS SE & CO. KGAA, among others.
Reasons to Purchase this Report
• Current and future anesthesia drugs market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• Identify the segment which is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Rise in the Number of Surgeries
According to the Center for Disease Control and Prevention (CDC), the total number of inpatient surgeries performed in the United States grew from 48 million in 2009 to 51.4 million in 2010, with cardiology, surgical, and obstetrical procedures being the most common ones. The number of surgeries being performed is rising every year. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as anesthetic drugs are used in surgical procedures to reduce the pain during surgery. Along with rising surgeries, other factors such as new anesthetic drugs and reduction in the cost of newly invented drugs are also driving the market.
Side Effects of General Anesthesia
General anesthetic drugs cause several side effects including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes, such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and to provide blood pressure medications if required. Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it, along with lack of skilled anesthetics and regulatory issues are restraining the market growth.
North America to dominate the Market
North America has the largest regional market share with revenue estimated to be over 32%. Some of the major driving forces that account for such growth in this region are the increase in a number of general and emergency surgeries, increase in cardiovascular and respiratory diseases, and rise in aging population. From the technology point of view, advancements in the development of new anesthesia drugs are a prime driving force of the market. Asia-Pacific was estimated to register the fastest CAGR through the forecast period (2018-2023).
Key Developments in the Market
• September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
• April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.
Major Players: BAXTER HEALTHCARE, HOSPIRA, ABBOTT LABORATORIES, ASTRA ZENECA, ROCHE HOLDING AG, B. BRAUN MELSUNGEN AG, ABBVIE, BOEHRINGER INGELHEIM, EISAI, FRESENIUS SE & CO. KGAA, among others.
Reasons to Purchase this Report
• Current and future anesthesia drugs market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• Identify the segment which is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
